Buscar
Mostrando ítems 1-10 de 628
Multidrug-resistant tuberculosis
(The Brazilian Journal of Infectious Diseases, 2013)
Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.
(American Thoracic Society, 2020)
RATIONALE: The World Health Organization recommends the use of isoniazid alone or in combination with rifapentine to treat latent tuberculosis infection. The recent rise of drug-resistant tuberculosis has complicated the ...
Advances in drug discovery of new antitubercular multidrug-resistant compounds
(2017-06-01)
Tuberculosis (TB), a disease caused mainly by the Mycobacterium tuberculosis (Mtb), is according to the World Health Organization (WHO) the infectious disease responsible for the highest number of deaths worldwide. The ...
Reported cases of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis in Salvador, Brazil
(Sociedade Brasileira de Medicina Tropical, 2017)
Multidrug-resistant tuberculosis among male inmates in Rio de Janeiro, Brazil
(Sociedade Brasileira de Microbiologia, 2019)
Tuberculosis genetic epidemiology: A latin american perspective
(MDPI, 2019)
There are an estimated 10 million new cases of tuberculosis worldwide annually, with 282,000 new or relapsed cases each year reported from the Americas. With improvements in genome sequencing technology, it is now possible ...
Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru
(Wiley, 2015)
OBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that ...
Predictors of mortality in multidrug-resistant tuberculosis patients from Brazilian reference centers, 2005 to 2012
(Brazilian Society of Infectious Diseases, 2020)
Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru
(Wiley, 2015)
Objective: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. Methods: We studied new smear-positive TB adults that were started on MDR TB treatment or that ...
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis
(2019-04-15)
Identification of new antibiotics suitable for the treatment of tuberculosis is required. In addition to selectivity, it is necessary to find new antibiotics that are effective when the tuberculous mycobacteria are resistant ...